BeiGene Says BRUKINSA Data At American Society Of Clinical Oncology (ASCO) Annual Meeting In Chicago Underscore Differentiated Clinical Profile For Treatment Of CLL And SLL

The presentations highlight analyses of the efficacy and safety of BRUKINSA compared to other Bruton's tyrosine kinase inhibitors (BTKis) used to treat chronic lymphocytic leukemia (CLL) and small lym

BenzingaMay 24 06:05 ET

Asia-Pacific Markets in Red as Traders Digest RBA May Policy Minutes; Eyes on FOMC Minutes

Seeking AlphaMay 21 03:29 ET

Hengrui diet pills went overseas for 6 billion US dollars, and this time they are no longer making wedding gowns for others | Insight Research

Through an innovative transaction structure, Hengrui uses minimal risk to obtain the highest potential overseas returns, while providing shareholders with more stable returns.

wallstreetcnMay 16 20:08 ET

Asia-Pacific Markets Mixed After China's Trade Data and BOJ Flags Inflation Risks, Eyes on US Key Figures

Seeking AlphaMay 9 03:21 ET

BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BeiGene Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Financial Results.

BenzingaMay 8 10:31 ET

BeiGene GAAP EPADS of -$2.41 Beats by $0.48, Revenue of $751.65M Beats by $76.42M

Seeking AlphaMay 8 06:16 ET